Expressional analysis of p16 and cytokeratin19 protein in the genesis of oral squamous cell carcinoma patients

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 6, 2014, Pages 1524-1530

  Babiker, Ali Yousif ^a   Rahmani, Arshad H ^b   Abdalaziz, Mohamed S ^c   Albutti, Aqel ^b   Aly, Salah M ^b   Ahmed, Hussain Gadelkareem ^d  

^a University of Sciences and Technology   (Sudan)

^b QASSIM UNIVERSITY   (Saudi Arabia)

^c SUDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Sudan)

^d UNIVERSITY OF KHARTOUM   (Sudan)

Author keywords

CK 19 and IHC; Oral squamous cell carcinoma

Indexed keywords

CYTOKERATIN 19; MONOCLONAL ANTIBODY; PROTEIN P16;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER STAGING; CARCINOGENESIS; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUTH INFLAMMATION; MOUTH SQUAMOUS CELL CARCINOMA; PROTEIN EXPRESSION ASSAY; TUMOR GROWTH;

EID: 84904043712     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Mehdi SJ, Ali A, Rizvi MA. Parkin Gene Alterations in Ovarian Carcinoma from Northern Indian population. Pathol Onco Res 2010; 17: 579-586.
2. Ahmed HG, Abusail SM, Eltom FM and Babiker AY. Frequency and genotype of human papillo-mavirus among Sudanese patients with head and neck tumors. Ecancer 2012; 6: 282.
3. Aldebasi YH, Rahmani AH, Khan AA, Aly SM. The effect of vascular endothelial growth factor in the progression of bladder cancer and diabetic retinopathy. Int J Clin Exp Med 2013; 6: 239-51.
4. Babiker AY, Eltom FM, Abdalaziz MS, Rahmani A, Abusail S, Ahmed HG. Screening for high risk human papilloma virus (HR-HPV) subtypes, among Sudanese patients with oral lesions. Int J Clin Exp Med 2013; 6: 275-281.
5. Rahmani AH, Alzohairy M, Babiker AY, Khan AA, Aly SM and Rizvi MA. Implication of androgen receptor in urinary bladder cancer: a critical mini review. Int J Mol Epidemiol Genet 2013; 4: 150-155.
6. Boyle P, Macfarlane GJ, Maisonneuve P, Zheng T, Scully C, Tedesco B. Epidemiology of mouth cancer in 1989: a review. JR Soc Med 1990; 83: 724-730.
7. 16INK4a, TGF-beta, and contact inhibition. Cell 1999; 97: 53-61.
8. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specifc inhibition of cyclin D/CDK4. Nature 1993; 366: 704-707.
9. 16INK4a in oral premalignant lesions. Oncogene 1997; 14: 1799-1803.
10. 16INK4a and p14ARF in patients with severe oral epithelial dysplasia. Cancer Res 2002; 62: 5295-5300.
11. Riese U, Dahse R, Fiedler W, Theuer C, Kosci-elny S, Ernst G, Beleites E, Claussen U and von Eggeling F. Tumour suppressor gene p16 (CD-KN2A) mutation status and promoter inactiva-tion in head and neck cancer. Int J Mol Med 1999; 4: 61-65.
12. 16INK4A and cyclin D1 in the tumourigenesis of oral squamous cell carcinomas. Cancer Lett 2000; 160: 3-8.
13. Kanaji N, Bandoh S, Fujita J, Ishii T, Ishida T, Kubo A. Compensation of type I and type II cy-tokeratin pools in lung cancer. Lung Cancer 2007; 3: 295-302.
14. Nie M, Zhong L, Zeng G, Li B. The changes of cytokeratin 19 during oral carcinogenesis. Zhonghua Kou Qiang Yi Xue Za Zhi 2002; 37: 187-90.
15. Zhong LP, Chen WT, Zhang CP. Increased CK19 expression correlated with pathologic differentiation grade and prognosis in oral squamous cell carcinoma patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 104: 377-384.
16. Su L, Morgan PR, Thomas JA. Expression of keratin 14 and 19 mRNA and protein in normal oral epithelia, hairy leukoplakia, tongue biting and white sponge nevus. J Oral Pathol Med 1993; 22: 183-9.
17. Rahmani A, Alzohairy M, Mandal AK, Rizvi MA. Expressional Evaluation of Androgen Receptor in Transitional Cell Carcinoma of Urinary Bladder Patients. British Journal of Medicine and Medical Research 2011; 1: 233-238.
18. Kreimer AR, Clifford GM, Boyle P and Frances-chi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomark-ers Prev 2005; 14: 467-475.
19. Warnakulasuriya S, Sutherland G and Scully C. Tobacco, oral cancer, and treatment of dependence. Oral Oncol 2005; 41: 244-260.
20. Blot WJ, McLaughlin JK and Winn DM. Smoking and drinking in relation to oral and pharyn-geal cancer. Cancer Res 1998; 48: 3282-3287.
21. Warnakulasuriya S, Trivedy C and Peters TJ. Areca nut use: an independent risk factor for oral cancer. BMJ 2002; 324: 799-800.
22. World Health Organization (WHO). Control of oral cancer in developing countries. Bull 1984; 62: 817-830.
23. Rahmani A, Alzohairy M, Babiker AY, Rizvi M and Ahmad GH. "Clinicopathological signif-cance of PTEN and bcl2 expressions in oral squamous cell carcinoma". Int J Clin Exp Pathol 2012; 5: 965-971.
24. Rahmani A, Alzohairy M, Habeeb K, Shish AK, Rizvi MA. Expressional evaluation of Vascular Endothelial Growth Factor (VEGF) protein in urinary bladder carcinoma patients exposed to cigarette smoke. Int J Clin Exp Pathol 2012; 5: 195-202.
25. Ahmed HG and Mahgoob RM. Impact of Toom-bak dipping in the etiology of oral cancer: Gender-exclusive hazard in the Sudan. J Can Res Ther 2007; 3: 127-130.
26. Ginawi IM, Mahgoub EA and Ahmed HG. Immu-nophenotyping of HPV types 16 and 18 among Sudanese patients with oral lesions. Oman Med J 2012; 27: 196-200.
27. Natarajan E, Saeb M, Crum CP, Woo SB, Mckee PH, Rheinwald JG. Co-expression of p16 (INK4A) and laminin 5 gamma2 by microinva-sive and superfcial squamous cell carcinomas in vivo and by migrating wound and senescent keratinocytes in culture. Am J Pathol 2003; 163: 477-91.
28. Rocco JW, Sidransky D. p16(MTS-1/CDKN2/ INK4a) in cancer progression. Exp Cell Res 2001; 264: 42-55.
29. Poi MJ, Yen T, Li J. Somatic INK4a-ARF locus mutations: a significant mechanism of gene inactivation in squamous cell carcinomas of the head and neck. Mol Carcinog 2001; 30: 26-36.
30. Buajeeb W, Poomsawat S, Punyasingh J, San-guansin S. Expression of p16 in oral cancer and premalignant lesions. J Oral Pathol Med 2009; 38: 104-108.
31. Pande P, Mathur M, Shukla NK, Ralhan R. PRb and p16 protein alterations in human oral tu-morigenesis, Oral Oncol 1998; 34: 396-403.
32. Zhong LP, Chen WT, Zhang CP. Increased CK19 expression correlated with pathologic differentiation grade and prognosis in oral squamous cell carcinoma patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 104: 377-84
33. Toyoshima T, Vairaktaris E, Nkenke E, Schlegel KA, Neukam FW, Ries J. Cytokeratin 17 mRNA expression has potential for diagnostic marker of oral squamous cell carcinoma. J Cancer Res Clin Oncol 2008; 134: 515-21.
34. Fillies T, Werkmeister R, Packeisen J, Brandt B, Morin P, Weingart D, Joos U, Buerger H. Cyto-keratin 8/18 expression indicates a poor prognosis in squamous cell carcinomas of the oral cavity. BMC Cancer 2006; 6: 10.